Talat Afnan, Khan Aleena A, Nasreen Samia, Wass John A
Medicine, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore, PAK.
Gynaecology, Combined Military Hospital Lahore Medical College and Institute of Dentistry, Lahore, PAK.
Cureus. 2019 Sep 15;11(9):e5661. doi: 10.7759/cureus.5661.
Background Derangements in thyroid hormone levels can cause multiple complications in the mother and the foetus. Thyroid stimulating hormone (TSH) and free thyroxine (free T4 or FT4) levels are used to screen for maternal thyroid dysfunction; these should be compared with population based trimester-specific reference ranges. Our goal was: to determine the prevalence of various thyroid derangements, in early pregnancy, according to the current reference ranges available; to determine the need for trimester specific reference ranges for the local population. Methods A multi-centric, cross sectional population survey was conducted in Lahore, Pakistan. Serum TSH and FT4 levels were measured at the hormone lab of the Pathology department of Combined Military Hospital (CMH) Lahore. The results were entered and analysed using Statistical Package for the Social Sciences (SPSS) version 23. Results In the 293 women sampled, mean FT4 and TSH levels were 15.03 (±5.62) pmol/L and 2.53 (±6.82) mIU/L respectively. According to the laboratory specific reference ranges, the prevalence of overt hyperthyroidism was 4.10%, (mean TSH= 0.03mIU/L); subclinical hyperthyroidism was 16.38%, (mean TSH= 0.17mIU/L); normal 70.65%, (mean TSH = 1.29mIU/L); subclinical hypothyroidism 4.44%, (mean TSH= 15.11mIU/L); overt hypothyroidism 4.44%, (mean TSH = 20.60mIU/L). Conclusion Our study showed a significant prevalence of thyroid dysfunction in the first trimester of pregnancy, and therefore highlights the need for more rigorous thyroid screening of women, in early pregnancy. There is a need to monitor these women in order to reduce maternal and foetal complications. Trimester specific reference ranges for thyroid hormones need to be developed in Pakistan.
甲状腺激素水平紊乱可导致母亲和胎儿出现多种并发症。促甲状腺激素(TSH)和游离甲状腺素(游离T4或FT4)水平用于筛查孕妇甲状腺功能障碍;应将这些水平与基于人群的孕龄特异性参考范围进行比较。我们的目标是:根据现有的参考范围确定妊娠早期各种甲状腺紊乱的患病率;确定当地人群孕龄特异性参考范围的必要性。方法:在巴基斯坦拉合尔进行了一项多中心横断面人群调查。在拉合尔联合军事医院(CMH)病理科的激素实验室测量血清TSH和FT4水平。使用社会科学统计软件包(SPSS)23版录入并分析结果。结果:在抽样的293名女性中,平均FT4和TSH水平分别为15.03(±5.62)pmol/L和2.53(±6.82)mIU/L。根据实验室特定的参考范围,显性甲状腺功能亢进的患病率为4.10%(平均TSH = 0.03mIU/L);亚临床甲状腺功能亢进为16.38%(平均TSH = 0.17mIU/L);正常为70.65%(平均TSH = 1.29mIU/L);亚临床甲状腺功能减退为4.44%(平均TSH = 15.11mIU/L);显性甲状腺功能减退为4.44%(平均TSH = 20.60mIU/L)。结论:我们的研究表明妊娠早期甲状腺功能障碍的患病率较高,因此强调了在妊娠早期对女性进行更严格甲状腺筛查的必要性。有必要对这些女性进行监测,以减少母婴并发症。巴基斯坦需要制定甲状腺激素的孕龄特异性参考范围。